Chronic bacterial prostatitis: efficacy of short-lasting antibiotic therapy with prulifloxacin (Unidrox®) in association with saw palmetto extract, lactobacillus sporogens and arbutin (Lactorepens®).
- 2014-07-19
- RCT · n = 210
- BMC urology 14
- Gian Maria Busetto
- Riccardo Giovannone
- Matteo Ferro
- Stefano Tricarico
- Francesco Del Giudice
- Deliu Victor Matei
- Ottavio De Cobelli
- Vincenzo Gentile
- Ettore De Berardinis
- PubMed: 25038794
- DOI: 10.1186/1471-2490-14-53
- High evidence
- Large Human Trial
- Clinical
Biological recurrence at 2 months in Group A was observed in 21 patients (27.6%) and in Group B in 6 patients (7.8%).
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes
- Dose
- 320 mg/day